Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
about
ApoE production in human monocytes and its regulation by inflammatory cytokinesBiology of Saccular Cerebral Aneurysms: A Review of Current Understanding and Future DirectionsThrombosis in ST-elevation myocardial infarction: Insights from thrombi retrieved by aspiration thrombectomyThe biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patientsUnderstanding the role of B cells in atherosclerosis: potential clinical implicationsT cells in atherosclerosisMouse models of atherosclerosis: a historical perspective and recent advances.B cells and atherosclerosis.Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No MoreHelix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.A functionally significant polymorphism in ID3 is associated with human coronary pathologyB cell subsets in atherosclerosis.Batf3-dependent CD8α+ Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5 Expression in Plaque Macrophages.Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells.Pannexin- and Connexin-Mediated Intercellular Communication in Platelet Function.B cells and humoral immunity in atherosclerosisInflammation and its resolution as determinants of acute coronary syndromes.Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.Bone marrow deficiency of MCPIP1 results in severe multi-organ inflammation but diminishes atherogenesis in hyperlipidemic mice.MiR-142-3p attenuates the migration of CD4⁺ T cells through regulating actin cytoskeleton via RAC1 and ROCK2 in arteriosclerosis obliterans.Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures.Atherosclerosis in systemic lupus erythematosus.Systemic lupus erythematosus and thrombosis.Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humansPeripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy.How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?Animal models of atherosclerosis.A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex.T cell immunity and cardiovascular metabolic disorders: does metabolism fuel inflammation?Biology of intracranial aneurysms: role of inflammation.STAT4 deficiency reduces the development of atherosclerosis in mice.Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.Endothelial-to-mesenchymal transition drives atherosclerosis progression.Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal ModelsLithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor.Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease.Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".S-nitrosylation of ARH is required for LDL uptake by the LDL receptor.
P2860
Q21559536-2E202D4B-AEE9-433B-80EF-BF0F90692380Q26738382-8E8F1E0A-47A5-4738-B3A9-2CF85A0AC518Q26746148-0FD4E01E-F263-4F04-A57E-8DDCFE637857Q26862601-B781A079-B016-4C7D-A4FF-E9DE15F9DFF4Q26991813-8AB67E61-10F3-47B9-9135-8AA578CF3F38Q27025697-DA191679-81BA-4DAF-951A-30CCC132B68AQ30238973-3F19CFDC-064B-4862-9461-99E38241BE36Q30252928-94195A53-B252-460E-98F4-9D371210E2E2Q30381851-A63E57ED-84D7-40B1-9D41-F7B06FF63681Q30413616-17E5A431-846A-4DA6-AB6D-4F13DD09ABC0Q30414349-F8D582E1-CE4C-487B-ACC9-FE9548048F6AQ30423324-3A00F9AE-957A-4201-8AE4-267864469F18Q30847000-AE9569E6-41BC-4FEA-8F8D-A9DD71FF703AQ31082179-CFECDF74-E770-4771-AEF9-8BD01DBE8258Q33560035-445C9C73-A613-461F-920D-78A0862F5470Q33624852-1819C90C-AB46-44CE-AB2A-560D652833BEQ33789638-307C64C0-8DA5-49F1-A2D3-8006A5E64042Q33834800-6022EDFF-1B73-4471-BA8D-DD8CD6413016Q34322056-B6C9FF96-7430-42F6-A15F-F8328B0FA95BQ35040388-D32F8571-756D-496F-B311-1F8AAFAEE282Q35152246-AE75C8A1-36FD-4D4A-B21E-64850279524FQ35470124-99A47C65-9B37-48A3-AD0A-52BE681326A5Q35525108-C2325CB9-8D4A-46C6-8B8F-BDBC85B71B1DQ35530248-415ADC85-1555-4622-8129-F8124C210D15Q35558887-C1ECCC69-A765-44F7-9B1E-872CC1C1BAD3Q35654752-D10E0F0B-63E0-468D-802A-17A134FF7B5BQ35723160-41661188-FB20-406E-B76A-94891790AD9EQ35738372-B2A30ADE-CF77-47BD-9291-A3F00E11806FQ35903298-6262EC95-C3BE-4DF7-8537-C7A3DF448110Q35909380-31BE5BE7-78C7-4D3D-8D4D-B36C272F4DC2Q36057159-B5742705-7A79-402C-902E-2E3B43DCDD5AQ36211346-1C8DE1EF-E9F7-45D1-9745-506D768ED4BEQ36257181-4B2FB34E-BD5E-4701-A2ED-F21D0CD62202Q36291435-BCBC5FCB-175C-42A1-ACE9-D3CAAD8A3010Q36335841-5DCDF643-6400-4D12-8D39-4C99DCF8FD5EQ36366126-AED34D73-5F32-429B-B877-9AA625735A96Q36368928-388A39E5-FD01-430D-B5CE-A07BC3A74449Q36374549-262395B5-8D7F-4DAA-9B8F-D6055F14C32FQ36654171-07D4AA63-BB81-4FFD-A6FD-31B617F6FCE0Q36822549-51EB71D9-1188-4232-B682-26EAD5DDFCEB
P2860
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@en
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@nl
type
label
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@en
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@nl
prefLabel
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@en
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@nl
P2860
P356
P1476
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
@en
P2093
Charlotte Lahoute
Olivier Herbin
P2860
P304
P356
10.1038/NRCARDIO.2011.62
P407
P577
2011-04-19T00:00:00Z